Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Adjuvant Therapy for Salivary Gland Carcinomas

MUTLAY SAYAN, PRASHANT VEMPATI, BRETT MILES, MARITA TENG, ERIC GENDEN, ELIZABETH G. DEMICCO, KRZYSZTOF MISIUKIEWICZ, MARSHALL POSNER, VISHAL GUPTA and RICHARD L. BAKST
Anticancer Research August 2016, 36 (8) 4165-4170;
MUTLAY SAYAN
1University of Vermont, College of Medicine, Burlington, VT, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PRASHANT VEMPATI
2Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRETT MILES
3Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARITA TENG
3Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIC GENDEN
3Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELIZABETH G. DEMICCO
4Department of Pathology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KRZYSZTOF MISIUKIEWICZ
5Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARSHALL POSNER
5Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VISHAL GUPTA
2Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RICHARD L. BAKST
2Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Richard.Bakst{at}mountsinai.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Kaplan-Meier analysis of 3-year overall survival based on the type of adjuvant therapy (p=0.141).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Kaplan-Meier analysis of 3-year locoregional control based on the type of adjuvant therapy (p=0.383).

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 36, Issue 8
August 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adjuvant Therapy for Salivary Gland Carcinomas
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Adjuvant Therapy for Salivary Gland Carcinomas
MUTLAY SAYAN, PRASHANT VEMPATI, BRETT MILES, MARITA TENG, ERIC GENDEN, ELIZABETH G. DEMICCO, KRZYSZTOF MISIUKIEWICZ, MARSHALL POSNER, VISHAL GUPTA, RICHARD L. BAKST
Anticancer Research Aug 2016, 36 (8) 4165-4170;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Adjuvant Therapy for Salivary Gland Carcinomas
MUTLAY SAYAN, PRASHANT VEMPATI, BRETT MILES, MARITA TENG, ERIC GENDEN, ELIZABETH G. DEMICCO, KRZYSZTOF MISIUKIEWICZ, MARSHALL POSNER, VISHAL GUPTA, RICHARD L. BAKST
Anticancer Research Aug 2016, 36 (8) 4165-4170;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands
  • Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Oral 5-FU Derivatives After Progression of HR+/HER2− Metastatic Breast Cancer on CDK4/6 Inhibitor
  • Postoperative Complications, Including Minor Complications, Worsen Prognosis After Laparoscopic Distal Gastrectomy for Gastric Cancer
  • Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer
Show more Clinical Studies

Keywords

  • Salivary gland carcinoma
  • adjuvant therapy
  • radiotherapy
  • chemoradiotherapy
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire